HigoSense, a Warsaw, Poland-based digital healthcare provider, raised €5m in Series A funding.
The round was led by Cogito Capital Partners with participation from existing early-stage investors, the founders of RTB House.
The company intends to use the funds to expand its solution in new markets across Europe, the Middle East and Asia.
Founded in 2017 by a team of serial entrepreneurs and medtech specialists led by Łukasz Krasnopolski, CEO, HigoSense is a provider of a mobile medical examination device supported by a mobile app and an online AI-powered health diagnostic platform. The company enables physicians to perform a high-quality remote patient examination, and patients to perform a self-examination and collect diagnostic data prior to or during a telehealth session.
The HigoSense device is a modular examination tool consisting of a primary device and five extension modules, each dedicated to different diagnostic functions: thermometer, throat spatula, stethoscope, otoscope and derm hood, enabling the patients and doctors to remotely examine body temperature, throat, heart, lungs, ears, and skin.
The App guides the patients and physicians step-by-step through the medical examination with the Higo device and gives instant access to their health records.
The company also offers a telehealth platform integrated with the device, where patient data is stored; the platform includes the Higo Doctor Portal enabling physicians to interpret video, audio, and interview data.
The software behind the device and the platform is powered by AI-enabled algorithms enhancing patient experience and supporting physicians in their analysis of medical data collected.